How Does Molnunorm Work Against the Coronavirus?

 

How Does Molnunorm Work Against the Coronavirus? 
(Molnupiravir Capsules 200 mg)

Although researchers around the world have developed various therapies to combat COVID-19, no single method has been the focus. However, recently, the focus has shifted to the development of antiviral drugs that could attack the new coronavirus directly instead of suppressing the symptoms of its infection or boosting the body's immunity, etc.

The development of such antiviral drugs is a exacting task for several reasons.

 

Once a virus has entered a cell, it depends on the cell’s machinery to replicate, unlike many most bacteria. So drugs designed to target the virus could have detrimental effects on the host cells as well.

MOLNUNORM' CAPS 200MG. A new entrant in the Indian Market, to fight with COVID-19. It is also been assumed as the replacement of Remedesvir .It is the world's first oral antiviral drug approved by USFDA, UKMHRA and CDSCO. It is approved for the treatment of adult patient with covid-19 with oxygen level 93% and having risk of progression of the disease which include hospitalization or death. This drug has to be taken every 3 hrs. 200mg caps for 5 days. With this drug you can skip hospitalization. Children below 18 years to be avoided. DCGI has given approval for this drug for Emergency Use Authorization (EUA) for adult patient in India. Each Caps costing around Rs 62.5/-. With a packing of 1*40's in a Jar.

Our product will be available in the market by January 2022 ending and it should reach every patient to avoid all the inconveniences faced during this period.

Dr. Naidu Sai Gautham, Managing Director, HETIKA PHARMACEUTICALS LLP
(An ISO 9001:2015 Certified Company), Hyderabad, in a press release said.
 

 

+91-8074662468
info@hetikapharmaceuticals.com
 
H.No. 2-22-310/107C, Western Hills Colony, Road No. 4. Addagutta Society
Near Arjun Theater, Kukatpally, Hyderabad, Telangana 500072, India